D'Silva Andrew J. — SEC insider filings

SEC reporting owner CIK 2083717. 8 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2025-10-07 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
OptimizeRx Corp (OPRX)Chief Business Officer8——10

Insider filings — D'Silva Andrew J.

FiledFormIssuerReported transactionsSource
2026-10-024OptimizeRx Corp (OPRX)Tax withholding (F): 414 @ $8.39EDGAR
2026-09-024OptimizeRx Corp (OPRX)Tax withholding (F): 1,432 @ $7.86EDGAR
2026-08-244OptimizeRx Corp (OPRX)Tax withholding (F): 1,243 @ $7.71EDGAR
2026-08-244OptimizeRx Corp (OPRX)Grant/award (A): 57,600 @ $0EDGAR
2025-12-224OptimizeRx Corp (OPRX)Tax withholding (F): 703 @ $13.51EDGAR
2025-12-154OptimizeRx Corp (OPRX)Tax withholding (F): 868 @ $14.03EDGAR
2025-11-074OptimizeRx Corp (OPRX)Tax withholding (F): 414 @ $18.98 · Tax withholding (F): 794 @ $18.75EDGAR
2025-10-074OptimizeRx Corp (OPRX)Grant/award (A): 10,417 @ $0 · Grant/award (A): 23,437 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2083717 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs